A B S T R A C T The erythropoietic effect of various thyroid hormones has been studied using erythroid colony formation by canine marrow cells. Although erythropoietin was required for colony growth, physiologic levels ofthyroid hormones significantly enhanced colony numbers. The order of potency of the thyroid compounds in their in vitro erythropoietic effect parallels their known calorigenic potency in vivo, suggesting that the in vitro effect is physiologically relevant. A series ofstudies linked the mechanism ofthyroid action to adrenergic receptors on responsive cells. Propranolol, a global ,8-blocker, inhibited thyroid hormoneresponsive erythroid colonies. When adrenergic antagonists having different blocking characteristics were added to culture, the thyroid hormone effect was blocked by those compounds having ,82-subspecificity.
INTRODUCTION
Disorders of thyroid function are generally accompanied by alterations in erythropoiesis. Although often masked by parallel changes in plasma volume, a reduced erythrocyte mass commonly occurs in patients with hypothyroidism. In the absence of complicating deficiency states, thyroid hormonal replacement restores the erythrocyte mass to normal (1) . In contrast, most hyperthyroid patients have an elevated erythrocyte mass (2) . Thyroid hormone increases erythrocyte production in euthyroid experimental animals as well (3) . This enhanced erythropoiesis has been attributed to a direct hormonal effect on the erythroid marrow (4, 5) and to increased erythropoietin (ESF)l secretion (6, 7) . However, since the studies were carried out in vivo, the calorigenic effect of thyroid hormones on overall metabolism must also be considered. Most recently, Golde et al. (8) have reported in vitro enhancement of murine erythroid colony growth by various thyroid hormones, suggesting a direct effect of these hormones on erythropoietic proliferation.
Erythroid colony growth is known to be modulated by several compounds, including 8-adrenergic agonists, linked to the adenyl cylcase/cyclic AMP system (9) . Several studies suggest that thyroid hormones may also affect cell functions by increasing the intracellular concentration of cAMP (10) (11) (12) . The observation that certain clinical manifestations of hyperthy-roidism may result from enhanced ,3-adrenergic responsiveness (13) is consistent with the hypothesis that thyroid hormones interact with receptors having , 8-adrenergic properties. This study examines the influence of thyroid hormones on in vitro erythropoiesis as well as the interactions of these hormones with catecholamine receptors. The results demonstrate that thyroid hormones directly enhance erythroid proliferation. As monitored by the erythroid colony-forming technique, the effect ofthyroid hormones appears to be mediated by a receptor with (3-adrenergic properties. However, the receptor for thyroid hormones has different characteristics than the receptor for ,8-agonists.
METHODS
Erythroid colony assay. The method of Stephenson et al. (14) was employed for erythroid colony growth. Canine bone marrow cells were harvested and cultured as previously described (15 (15) . The number of colonies formed was directly dependent on the number of nucleated cells plated (15) .
To assess the effect of various thyroid hormone analogues on erythroid colony growth, microliter quantities of L-thy- in, and all compounds were subsequently diluted with, Hanks' balanced salt solution. In 1 ml ofmedia, the total concentration of L-T4 was 0.036 ,uM, and L-T3 was 0.38 nM before the addition of thyroid compounds. In concurrent control cultures, the amount of ethanol (1-10 ,ul) with NaOH or HCI present had no effect on erythroid colony growth.
Studies of thyroid-catecholamine interrelationships.
To examine the possible relationship between thyroid hormone and ,-adrenergic influences, the effect of the following agents on L-T4-enhanced canine erythroid colonies was stud- was employed as the f3-adrenergic agonist (19) . To test the hypothesis that thyroid hormones may influence a-receptor numbers, several mixing experiments with both optimal (0.1 ,uM) and suboptimal concentrations (10 nM) of L-T4 and L-isoproterenol were performed.
Cell separation by velocity sedimentation. The colonyforming cell populations responding to ESF, isoproterenol and L-T4, were compared by the technique of velocity sedimentation at unit gravity (20) as employed in this laboratory (21) . Erythrocyte contamination of the cell suspension was reduced before loading the gradient by taking only the buffy coat from the cell pellets after each Hanks' balanced salt solution wash, thereby achieving a nucleated: nonnucleated cell ratio of 1:3-4.
RESULTS
Under the described conditions, colonies of hemoglobin-synthesizing cells appeared only in cultures containing added ESF. The number ofcolonies formed was directly dependent on the logarithm of the concentration of ESF. In cultures of canine marrow cells, maximal colony formation was observed with ESF concentrations of 1-2 IRP U/ml (Fig. 1) .
When various thyroid hormones and their analogues were added to cultures containing ESF, enhanced erythroid colony formation was consistently observed. This enhancement of colony growth depended on the concentration of thyroid hormone ( (9) have shown that the peak erythropoietic effect of isoproterenol is at 0.1 ,uM, the same as L-T4. As shown in Fig. 3 , propranolol blocks L-T4-enhanced erythroid colony growth. To determine the specificity of the inhibitory properties of propranolol, the blocking abilities of its stereospecific isomers were compared. As shown in Fig. 4 , inhibition ofcolony numbers occurs only with the biologically active Lisomer. However, while L-propranolol blocks the erythropoietic effect of L-T4, at least 103-fold less antagonist is needed to suppress isoproterenol-induced colonies (Fig. 3) . Thus, whereas the in vitro erythropoietic effects of both L-T4 and isoproterenol appear to be mediated by a receptor with f3-adrenergic proper- only an additive effect was seen at suboptimal concentrations of these hormones. The adrenergic subspecificity of the thyroid receptor was further characterized by comparing the ability of various adrenergic antagonists to inhibit L-T4-enhanced erythroid colony growth. Fig. 5 shows that L-T4 effects are reversed by 0.1 ,uM concentrations of propranolol (31(2) and butoxamine (12) , but not practolol (f3,) or phentolamine (a), suggesting that L-T4 influences a receptor with 832-characteristics. As in the case of inhibition by propranolol (Fig. 3) , a greater concentration of butoxamine was required to block the enhancing effect of L-T4 than that of isoproterenol (Fig. 6) .
Inasmuch as several thyroid compounds enhanced erythroid colony growth, the receptor subspecificity for all the erythropoietically active compounds was determined. In addition, the inhibitor concentrations required to block the thyroid hormone effects were compared. Fig. 6 demonstrates that the effects of both L-T4 (0.1 ,uM) and L-T3 (1 nM) were blocked by butoxamine at 0.1 ,uM. This same concentration of butoxamine was found to block completely the effect of all the thyroid analogues at their respective peak concentrations. The ,81-blocker, practolol, was inhibitory only at a concentration 102-fold higher than that required for butoxamine blockade. Thus, all the thyroid hormones examined appear to act through similar 1,2-receptors by this analysis.
Cell separation by velocity sedimentation. When cells responding to ESF, L-T4, and isoproterenol were analyzed by velocity sedimentation, the peak of ESFdependent erythroid colony-forming cells sedimented more rapidly (8.62±0 mm/h; n = 3) than the peak of L-T4-responsive cells (7.54+0 mm/h; n = 3, P = 0.05) (Fig. 7) . In addition, the profiles of L-T4 and L-isopro-
The effect ofvarious concentrations ofbutoxamine on L-T4-, L-T3-, and isoproterenol-enhanced erythroid colonies. The concentrations chosen for the enhancing factors had previously been shown to be optimal for these compounds. terenol-responsive cells coincided almost completely. The data suggest that these modulators affect the same cell population, one that is distinct from the majority of the ESF-responsive cells.
DISCUSSION
Although thyroid hormones have been shown to accelerate erythropoiesis in animals and man, the mechanism of this effect has not been clearly elucidated. Some investigators (6, 7, 22) have postulated that thyroid hormones exert their erythropoietic action through an elevation of ESF levels. However, others (4, 5, 23) have described augmented erythropoiesis independent of ESF activity, thus suggesting a direct effect on erythroid precursors. Most recently, Golde et al. (8) have provided direct evidence of enhanced in vitro erythropoiesis by thyroid hormones.
The observations reported here confirm a direct erythropoietic effect of thyroid hormones and characterize some of the mechanisms by which these hormones act. Thyroid hormones increase canine erythroid colony formation in vitro under conditions in which ESF levels are controlled and general metabolic changes are no longer a factor. Separation oftarget cells by velocity sedimentation suggests that L-T4 affects a population that is somehow distinct from the majority of ESF-responsive progenitors. Inasmuch as the method separates cells primarily according to their size (20) , such separation may reflect differences in maturation (24) and (or) stage ofcell cycle (25) . These observations support the contention that the erythroid progenitor cell responding to thyroid hormone may represent a subpopulation of erythroid colony-forming units; whether it is more or less differentiated than the majority of the ESF-responsive cells is not known.
The peak activities ofboth L-T4 and L-T3 were seen at physiologic concentrations (26) . In addition, the order of potency of the erythropoietic effect of thyroid compounds in vitro parallels their calorigenic potency in vivo. Several other systems have been described which demonstrate a similar order of in vitro thyroid hormone activity. Samuels et al. (27) described a rat pituitary cell line responsive to concentrations of thyroid hormones that were analogous to their known in vivo activity. In nuclear binding studies, Oppenheimer et al. (28) (30) , and Samuels et al. (31) . Thus, in several systems, including the erythroid colonyforming assay, the importance ofthe correlations ofthe thyroid analogue effects and their known biologic potency is affirmed. The activity of thyroid hormones at concentrations similar to those found in vivo suggests that the erythropoietic effect of these hormones has physiologic significance (32) .
Although most recent studies of thyroid action have focused on nuclear binding, Tata (33) has cautioned against equating biologic activity of thyroid hormones with such binding. Thus, thyroid hormone interactions with the cell membrane or cytosol may occur prior, or in addition, to binding to nuclear sites. In fact, binding at the cell membrane may be required to initiate hormone action, although little work has been done in this area.
Many hormones, including /-adrenergic agonists, bind initially to receptors at the cell membrane and influence cell function via adenyl cyclase-linked mechamisms (34) . Such a mechanism of action has also been suggested for thyroid hormones because of the observed relationship between thyroid hormonal status and adrenergic activity (13) . Evidence for such a hypothesis is provided by several observations. First, it has been proposed that thyroid hormone is capable of activating adenyl cyclase in vitro (10) , although the concentrations were pharmacologic. In addition, 38- adrenergic responsiveness in hypothyroid rats is reduced (11) , and phosphodiesterase activity correlates inversely with thyroid hormonal status (12) . Finally, augmentation of a catecholamine-sensitive adenyl cyclase system (35) (38) . Third, within the erythroid colony-forming system, the receptor subspecificity for both thyroid hormones and ,8-adrenergic agonists (9) appears to be of the P2-type.
However, there is a significant difference between L-T4-and isoproterenol-enhanced colony growth in the concentration at which p-blockade occurs. Propranolol inhibits L-T4-enhanced colonies at a 103-fold greater concentration than that which inhibits isoproterenolinduced colonies. Because ofthis difference, however, a mechanism of propranolol blockade, independent of ,82-receptors, remains a possibility, although such a non-pl-effect has not been described as having stereospecificity. Alternatively, it is possible that thyroid hormones and adrenergic compounds enhance erythroid colony growth by interaction with different p2-receptors. Thus, there may be two distinct, 2-receptors, one responsive to ,-adrenergic stimuli and the other to thyroid hormones. Additionally, thyroid hormones may somehow alter the sensitivity oferythroid colony-forming units to catecholamines or merely regulate the number of 8-receptors. However, inasmuch as there is a lack of synergism when optimal or suboptimal concentrations of thyroid hormones and 8-agonists are tested together, it is unlikely that the effect of thyroid hormones on erythroid colony growth is due to an increase in 8-receptors on the target cells.
Thus, the action of thyroid hormone upon in vitro canine erythroid colony formation appears to be mediated by an adrenergic-like receptor with ,2-specificity. The clinical parallel between thyroid disease states and adrenergic activity appears to be reflected in the thyroid-catecholamine interactions on mammalian erythroid proliferation. These findings suggest that alterations in hormone-target-cell interaction may characterize states of disordered thyroid function. 
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